Upfront Camrelizumab Plus Chemo Yields Survival Benefit in Advanced Esophageal SCC
NEW YORK (Reuters Health) - Adding camrelizumab to chemotherapy improves overall survival and progression-free survival...
Health News 2 me
healthnews2me.com
Tag: noncolorectal gastrointestinal
Immunotherapy Likely New Standard in Advanced Esophageal Cancer
Nivolumab (Opdivo) plus chemotherapy and nivolumab plus ipilimumab (Yervoy) were superior to standard chemotherapy in...